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Abstract 
Behavior therapy is effective for Persistent Tic Disorders (PTDs), but behavioral processes facilitating tic 
reduction are not well understood. One process, habituation, is thought to create tic reduction through 
decreases in premonitory urge severity. The current study tested whether premonitory urges 
decreased in youth with PTDs (N = 126) and adults with PTDs (N = 122) who participated in parallel 
randomized clinical trials comparing behavior therapy to psychoeducation and supportive therapy 
(PST). Trends in premonitory urges, tic severity, and treatment outcome were analyzed according to 
the predictions of a habituation model, whereby urge severity would be expected to decrease in those 
who responded to behavior therapy. Although adults who responded to behavior therapy showed a 
significant trend of declining premonitory urge severity across treatment, results failed to demonstrate 
that behavior therapy specifically caused changes in premonitory urge severity. In addition, reductions 
in premonitory urge severity in those who responded to behavior therapy were significant greater than 
those who did not respond to behavior therapy but no different than those who responded or did not 
respond to PST. Children with PTDs failed to show any significant changes in premonitory urges. 
Reductions in premonitory urge severity did not mediate the relationship between treatment and 
outcome in either adults or children. These results cast doubt on the notion that habituation is the 
therapeutic process underlying the effectiveness of behavior therapy, which has immediate 
implications for the psychoeducation and therapeutic rationale presented in clinical practice. 
Moreover, there may be important developmental changes in premonitory urges in PTDs, and 
alternative models of therapeutic change warrant investigation. 
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Persistent tic disorders (PTDs) such as Tourette’s Disorder (also known as Tourette’s syndrome) are 
neurodevelopmental disorders characterized by the presence of tics for at least 1 year (American 
Psychiatric Association, 2013). Tics are repetitive motor movements (e.g., hard blinking and head 
jerking) and vocalizations (e.g., grunting and repetition of words or phrases) that can cause significant 
functional impairment and distress (Houghton, Alexander, & Woods, 2016). PTDs primarily affect 
children and have a waxing-to-waning developmental course. The age of tic onset tends to be between 
4 and 6 years, and tics reach peak severity between ages 10–12 and often decline in severity during 
late adolescence (Bloch & Leckman, 2009). However, nearly one quarter of individuals with PTDs 
experience chronic tic symptoms into adulthood (Bloch and Leckman, 2009, Groth et al., 2017, 
Leckman et al., 1998). 
PTDs can be treated effectively with behavior therapy (Capriotti et al., 2014, Cook and Blacher, 2007, 
Piacentini et al., 2010, McGuire et al., 2014, Wilhelm et al., 2012), which is thought to facilitate 
conditioning experiences central to promoting tic reduction. Behavioral interventions approach tics as 
being initiated by aberrant neural functioning but perpetuated largely by conditioning processes 
surrounding core PTD symptoms (Conelea and Woods, 2008, Himle et al., 2006, Himle et al., 2014). 
Indeed, a neurobehavioral perspective on tics acknowledges that tics are supported by motor 
hyperexcitability within fronto-striatal neural circuits (Albin & Mink, 2006), but tics are maintained, in 
part, by operant reinforcement and respondent associations (reviewed by Himle et al., 2006). One 
crucial aspect of these conditioning processes involves the functional relation between certain somatic 
phenomena, known as premonitory urges (PMUs), and tics (reviewed by Houghton, Capriotti, Conelea, 
& Woods, 2014). 
A substantial body of literature has shown that individuals with PTDs experience PMUs, which are 
aversive sensations that precede and accompany tics (Cohen and Leckman, 1992, Kurlan et al., 1989, 
Kwak et al., 2003, Leckman et al., 1994, Leckman et al., 1993, Woods et al., 2005). Patients describe 
these experiences as various feelings of unfulfillment, irritation, and musculoskeletal tension (Bliss, 
Cohen, & Freedman, 1980). Whereas early conceptualizations considered tics to be involuntary (Caine, 
Polinsky, Kartzinel, & Ebert, 1979), accounts of PMU phenomena suggested that tics are better 
characterized as somewhat volitional and instigated by highly aversive PMUs, which are alleviated 
upon ticcing (Evers and van de Wetering, 1994, Kane, 1994, Lang, 1991). Several studies have 
supported this notion using an experimental paradigm comparing periods in which tic suppression is 
intermittently reinforced by monetary reward with periods when participants are instructed to tic 
freely and suppression is not rewarded (e.g., Capriotti et al., 2014, Himle et al., 2007, Woods and 
Himle, 2004). Results of these studies showed that tics can be suppressed for brief periods and that 
PMU strength increased during reinforced tic suppression and decreased during breaks from 
suppression. Furthermore, a recent study found that PMU strength increases prior to ticcing and 
decreases after ticcing (Brandt, Beck, Sajin, Baaske, et al., 2016). 
The neurobehavioral model of PTDs posits that the short-term reductions in PMUs following tic 
completion result in longer-term strengthening or maintenance of tics and PMUs (Himle et al., 2006). 
When individuals engage in prolonged tic suppression, they experience PMUs without ticcing, and 
PMUs are thought to dissipate (Woods et al., 2008). Thus, tic suppression might facilitate a PMU 
habituation process whereby repeated exposure to the PMU results in decreased physiological 
response to PMUs and similar sensory stimuli (Evers and van de Wetering, 1994, Himle et al., 2006, 
Hoogduin et al., 1997, Verdellen et al., 2008, Woods et al., 2000). PMU habituation is thought to occur 
both within individual periods of tic suppression (i.e., within treatment sessions) and between periods 
of suppression (i.e., across sessions). The notion of PMU habituation through tic suppression is similar 
to the rationale underlying exposure and response prevention (ERP) for obsessive-compulsive disorder 
(Abramowitz, 1996). However, ERP-based behavioral treatments for PTDs are thought to work by 
having clients engage in prolonged tic suppression and learn to habituate to the accompanying 
increases in PMUs (Verdellen, Keijsers, Cath, & Hoogduin, 2004), whereas ERP for obsessive-
compulsive disorder (OCD) involves deliberate exposure to fear-evoking stimuli and prevention of 
rituals and/or avoidance behaviors. 
Studies investigating PMU habituation have yielded mixed results. The first study to systematically 
investigate PMU habituation reported on 4 patients with Tourette’s Disorder (3 adults and 1 child) who 
received 10 sessions of ERP for PTDs (Hoogduin et al., 1997). Repeated-measures data from 3 of the 4 
participants showed evidence of short-term PMU habituation within sessions (i.e., decreases in urge 
ratings at the end of a session relative to the beginning of those same sessions). In an open trial of 19 
adults and children with PTDs who received the same ERP treatment protocol, longitudinal analyses 
showed evidence of PMU habituation both within and between sessions (Verdellen et al., 2008). 
However, three studies found a lack of evidence for within-session PMU habituation using differential 
reinforcement for tic suppression paradigms lasting 25–80 minutes (Capriotti et al., 2014, Himle et al., 
2007, Specht et al., 2013). 
These mixed findings may be at least partially due to methodological inconsistencies and shortcomings. 
First, studies examining PMU habituation have used samples of differing age ranges, despite the fact 
that there are important age-based differences in PMUs. Research has shown that while a majority of 
persons with PTDs aged 9 years or older report some type of PMU, younger children are less likely to 
report PMUs (Banaschewski et al., 2003, Leckman et al., 1993, Woods et al., 2005), suggesting younger 
children may show a less clear association between PMUs and tics throughout treatment. Indeed, 
studies that showed positive evidence of PMU habituation included both adults and children but were 
weighted toward adults (Hoogduin et al., 1997, Verdellen et al., 2008). For example, the sample in 
Verdellen et al. had a mean age of 23, and in the study by Hoogduin et al., the three participants who 
showed evidence of PMU habituation were adults while the one participant showing no PMU 
habituation was a child. By comparison, the studies that reported a lack of evidence for PMU 
habituation used younger samples consisting of children and adolescents (Capriotti et al., 2014, 
Capriotti et al., 2014, Himle et al., 2007, Specht et al., 2013). These results suggest that perhaps adults 
but not children experience PMU habituation during behavioral treatment. A second limitation of 
existing evidence for or against the habituation hypothesis is that lab-based tic suppression studies, on 
which the findings primarily have been based, may not generalize to clinical settings and have used 
relatively small sample sizes with no control groups (Capriotti et al., 2014, Himle et al., 2007, Specht et 
al., 2013). As such, future research is needed to examine PMUs using (a) studies that enable 
differential analyses for adults and children, (b) longitudinal designs that reflect real-world behavior 
therapy for PTDs, and (c) large samples with control conditions. 
The current study sought to examine PMU habituation as a mechanism of change within two, large, 
multi-site trials of behavior therapy, based primarily on habit reversal training (HRT; Azrin & Nunn, 
1973), versus supportive psychotherapy plus psychoeducation control for pediatric (Piacentini et al., 
2010) and adult (Wilhelm et al., 2012) PTDs. Data from the child trial were analyzed separately from 
the adult trial in order to examine age-based differences. Several predictions were made to examine 
whether PMU habituation occurred. First, PMU severity should have decreased across time for those 
who received behavior therapy but not for those who received a control treatment (Hypothesis 1), 
particularly in those who responded to treatment (Hypothesis 2). It was also predicted that pre- to 
posttreatment decreases in PMU severity should mediate the relationship between treatment 
condition and outcome (Kraemer, Wilson, Fairburn, & Agras, 2002) (Hypothesis 3). In addition, because 
some research has indicated that premonitory urges correlate positively with measures of OCD 
symptoms, anxiety, and depression (Eddy and Cavanna, 2013, Rozenman et al., 2015, Steinberg et al., 
2009, Woods et al., 2005), exploratory analyses were conducted to determine whether reductions in 
PUTS scores were associated with change on any secondary outcome measures used in the clinical 
trials. 
Material and Methods 
Participants 
In the child trial, a total of 178 children and adolescents were screened and 126 eligible youth enrolled 
between December 2004 and May 2007. Participants were recruited via psychiatry and psychology 
clinics, primary care and mental health referrals, schools, churches, community organizations, 
paid/public service notices, and ads in local media and on the Tourette Association of America website 
and newsletter. Inclusion criteria were (a) age 9–17 years, (b) Tourette’s Disorder or Persistent Tic 
Disorder of at least moderate severity, (c) English language fluency, and (d) IQ > 80. Children who were 
medication free or on a stable medication regimen were eligible to participate. For a more detailed 
description of inclusion criteria and sample characteristics, see Piacentini et al. (2010) and Specht et al. 
(2011), respectively. Participants were randomized to receive the index treatment, Comprehensive 
Behavioral Intervention for Tics (CBIT), consisting of habit reversal training (HRT) plus functional 
intervention (Woods et al., 2008; N = 61), or a comparison condition consisting of psychoeducation and 
supportive therapy (PST; N = 65). By the end of the 10-week treatment phase, 5 participants (8%) had 
discontinued behavior therapy, whereas 7 participants (11%) discontinued supportive therapy. 
In the adult trial, a total of 172 adults were screened and 122 eligible participants enrolled between 
December 2005 and May 2009. Participants were recruited via psychiatry and psychology clinics at 
major medical centers, flyers in public places, physician referrals, online advertisements, presentations 
at local patient organization meetings, and ads in local media. Inclusion criteria were identical to the 
child trial except that age was required to be ≥ 16. Participants on stable medication for at least 6 
weeks were allowed to participate. See Wilhelm et al. (2012) for a more detailed description of 
inclusion criteria and sample characteristics. Also similar to the child trial, participants were 
randomized to receive 10 weeks of CBIT (N = 63) or PST (N = 59). At the end of treatment, 7 
participants (11%) had discontinued behavior therapy, whereas 10 participants (17%) discontinued 
supportive therapy. 
Assessments 
The Yale Global Tic Severity Scale (YGTSS) is a clinician-rated assessment of tic severity (Leckman et al., 
1989). All current tics are rated on each dimension (score of 0–5) for motor and vocal separately and 
then totaled for a score of 0–25. The motor and vocal tic totals are summed for a combined total tic 
score (0–50). The YGTSS has adequate internal consistency (item-total correlations ranging from 0.78–
0.88) and interrater reliability (intra-class correlation coefficients ranging from 0.52–0.99) and 
acceptable convergent and divergent validity (Leckman et al.). 
The Premonitory Urge for Tics Scale (PUTS) is a self-report measure designed to assess PMU severity 
(Woods et al., 2005). The PUTS contains 9 items (displayed in Table 1) rated on a 4-point scale (1 = not 
at all true to 4 = very much true). Item responses are summed for a score ranging from 9 (no PMUs) to 
36 (high PMU severity). Internal consistency (Cronbach’s alpha coefficients = 0.79–0.85) and test-retest 
reliability has been reported in the acceptable to good range (2-week test-retest correlations = 0.79–
0.86), and concurrent validity of the PUTS is generally satisfactory (Crossley et al., 2014, Reese et al., 
2014, Steinberg et al., 2009, Woods et al., 2005). A recent study also found that the PUTS showed 
convergent validity with real-time urge intensity scores on visual analogue scale (Brandt, Beck, Sajin, 
Anders, & Munchau, 2016). However, studies have shown that the internal consistency and convergent 
validity of the PUTS is poorer in children younger than 10 as compared to youths older than 10 
(Steinberg et al., 2009, Woods et al., 2005). 
Table 1. Premonitory Urge for Tics Scale (PUTS) 
Item 
# 
Item Content 
1 Right before I do a tic, I feel like my insides are itchy. 
2 Right before I do a tic, I feel pressure inside my brain or body. 
3 Right before I do a tic, I feel “wound up” or tense inside. 
4 Right before I do a tic, I feel like something is not “just right” 
5 Right before I do a tic, I feel like something isn’t complete. 
Item 
# 
Item Content 
6 Right before I do a tic, I feel like there is energy in my body that needs to get out. 
7 I have these feelings almost all the time before I do a tic. 
8 These feelings happen for every tic I have. 
9 
After I do the tic, the itchiness, energy, pressure, tense feelings, or feelings that something isn’t 
“just right” or complete go away, at least for a little while. 
 
The Clinical Global Impressions–Improvement Scale (CGI-I; Guy & Bonato, 1970) is a single-item 
clinician-rated measure of overall treatment response. A trained rater indicates improvement or 
worsening via an 8-point rating scale ranging from 1–8, with scores of “very much improved” (1) and 
“much improved” (2) defining treatment response. Reliability of the CGI-I has shown to be high in 
other disorders (i.e., schizophrenia; Cronbach’s alpha = 0.69–0.96) (Ventura, Cienfuegos, Boxer, & 
Bilder, 2007). Validity coefficients are also high for the CGI-I across many different psychiatric 
conditions in both pharmacological and psychosocial treatment paradigms (Bandelow et al., 2006, 
Leon et al., 1993, Leucht and Engel, 2006, Spielmans and McFall, 2006, Zaider et al., 2003). 
Several other self-report questionnaires were used to measure relevant secondary outcomes in the 
clinical trials. In the child trial, secondary outcome measures included the Children’s Yale-Brown 
Obsessive-Compulsive Scale (Scahill et al., 1997), the attention problems subscale of the Child Behavior 
Checklist (Achenbach & Edelbrock, 1991), the Disruptive Behavior Rating Scale–Parent Version 
(Friedman-Weieneth, Doctoroff, Harvey, & Goldstein, 2009), the Child Depression Inventory (Helsel & 
Matson, 1984), the Screen for Child Anxiety Related Emotional Disorders as rated by children and 
parents (Birmaher et al., 1997), and the Childhood Anxiety Sensitivity Index (Silverman, Fleisig, Rabian, 
& Peterson, 2010). In the adult trial, secondary outcome measures included the Yale-Brown Obsessive-
Compulsive Scale (Goodman et al., 1989), the Beck Anxiety Inventory (Beck, Epstein, et al., 1988), and 
the Beck Depression Inventory (Beck, Steer, & Garbin, 1988). 
Procedure 
The child trial was conducted at three sites: The Johns Hopkins School of Medicine, the University of 
California, Los Angeles, and the University of Wisconsin-Milwaukee. The adult trial was conducted at 
three additional sites: Massachusetts General Hospital/Harvard Medical School, Yale University, and 
the University of Texas Health Science Center at San Antonio. Each of these sites also provided 
collaborative support in the form of administrative procedures, data management, rater training, and 
quality assurance across the two studies. Archival data analysis related to the present study was 
performed at Texas A&M University. All institutions obtained IRB approval for the project, procedures 
were performed in compliance with the Code of Ethics of the World Medical Association (Declaration 
of Helsinki), and the studies are publicly listed on the U.S. National Institutes of Health human subjects 
trial forum (ClinicalTrials.gov; NCT00218777, NCT00231985). All adult participants and parents of child 
participants provided written informed consent, and child participants provided assent. 
Participants in both trials completed 8 sessions of treatment across 10 weeks. CBIT consisted primarily 
of HRT (Azrin & Nunn, 1973) but also included psychoeducation, relaxation training, and a functional 
intervention aimed at mitigating tic triggers (e.g., anxiety, public performance) and consequences 
associated with increased ticcing (e.g., teasing, escape from responsibility). The control treatment, PST, 
consisted of psychoeducation and supportive psychotherapy (Goetz & Horn, 2005). PST precluded any 
instruction or advice pertaining to tic management strategies. Treatment conditions were matched in 
terms of time and therapist contact. For more detailed descriptions of therapeutic components, see 
Piacentini et al. (2010), Wilhelm et al. (2012), and Woods et al. (2008). 
The current study utilized assessment data, collected from participants’ self-reports, parent-reports, as 
well as trained clinical evaluators masked to treatment condition, from three time points: baseline (0 
weeks), midtreatment (5 weeks), and posttreatment (10 weeks). Missing data were addressed via 
imputation techniques (Piacentini et al., 2010, Wilhelm et al., 2012). 
Statistical Analysis 
To investigate the predictions that PMU severity would decline in those who received CBIT and 
particularly those who responded to CBIT, as compared to other participants, we conducted 2 × 2 × 3 
(treatment condition × response status × time) repeated-measures ANOVA tests. For both the child 
and adult data, Mauchly’s tests of sphericity were rejected (Χ2[2] = 12.27, p < 0.001; X2[2] = 16.25, p < 
0.001), so the ANOVAs were interpreted through Greenhouse-Geisser corrected results (ε = .897; ε = 
.863). Significant results were further investigated by conducting a one-way ANOVA and bonferroni 
post-hoc tests comparing the magnitude of PMU reductions across treatment between four groups of 
participants: participants who received CBIT and responded to treatment, participants who received 
CBIT and did not respond to treatment, participants who received PST and responded to treatment, 
and participants who received PST and did not respond to treatment. 
To investigate Hypothesis 3, that reductions in PMU severity would mediate the relationship between 
treatment assignment and outcome, a bootstrapping regression-based technique (Hayes & Preacher, 
2014) was used to measure the strength of the indirect effect of PUTS changes across treatment on the 
association between treatment assignment and changes in YGTSS scores from baseline to 
posttreatment. See Figure 1. The SPSS Macro “MEDIATE” was used to perform such analyses (Hayes, 
2014). The number of bootstrap samples was set to 5000, and a 95% bootstrap percentile confidence 
interval was used. A significant indirect effect is inferred when zero lies outside of the confidence 
interval. 
 
Figure 1. Proposed mediation path in which reductions in premonitory urges exert an indirect effect on 
the direct relationship between treatment assignment and treatment outcome (reductions in tic 
severity). 
Finally, exploratory analyses investigating the relationship between PMU severity reductions and 
changes in secondary outcome measures in the clinical trials were conducted using Pearson’s 
correlations. 
Results 
Child Trial 
Results were inconsistent with Hypotheses 1 and 2, in that PMU severity did not decrease over time for 
either PST or CBIT, nor in those who responded versus those who did not respond to treatment. There 
were no significant main effects of time, F(2, 204) = 1.59, p = 0.21, treatment condition, F(1, 102) = 
0.52, p = 0.47, or response status, F(1, 102) = 0.69, p = 0.41, and there were no significant interactions 
between time and treatment condition, F(2, 204) = 1.33, p = 0.27, time and response status, F(2, 204) = 
0.89, p = 0.41, or time and treatment and response status, F(2, 204) = 0.03, p = 0.96. See Figure 2. 
These results are neither consistent with the notion that CBIT results in PMU severity reductions nor 
with the hypothesis that PMU severity reduction is associated with treatment gains in children who 
receive behavior therapy for PTDs. 
 
Figure 2. Repeated measures ANOVA of premonitory urge (PMU) trends across treatment in the child 
trial. Note: CBIT = Comprehensive Behavioral Intervention for Tics; PST = psychoeducation and 
supportive psychotherapy; PUTS = Premonitory Urge for Tics Scale. Data points reflect estimated 
marginal means and 95% confidence intervals. 
When investigating whether changes in PMU mediated the relationship between treatment and 
outcome, there was a significant direct effect with regard to the relationship between treatment 
assignment and changes in YGTSS scores, F(1, 104) = 12.99, p < 0.001, but there was no significant 
indirect effect of PMU severity changes (Effect = 0.003; Lower Level Confidence Interval = -0.21, Upper 
Level Confidence Interval = 0.31). As such, results were inconsistent with Hypothesis 3. 
Reductions in PMU severity were not significantly correlated with changes in OCD symptoms, r(107) = 
.13, p = .17, ADHD symptoms, r(106) = .11, p = .26, disruptive behavior severity, r(104) = -.05, p = .62, or 
anxiety symptoms as measured by child, r(106) = .12, p = .21, or parent, r(107) = .11, p = .24. However, 
reductions in PMU severity were significantly correlated with reductions in depression symptoms, 
r(103) = .27, p = .006, and anxiety sensitivity, r(105) = .27, p = .006. 
Adult Trial 
Results were partially consistent with Hypotheses 1 and 2. PMU severity decreased over time in all 
participants, but a linear trend of PMU severity reduction was only apparent in those who received 
CBIT and responded to treatment versus those who did not respond to CBIT and persons who received 
PST. There was a significant main effect of time, F(2, 190) = 4.55, p = 0.012, d = 0.439, and no 
significant main effects of treatment assignment, F(1, 95) = 0.003, p = 0.96, or response status, F(1, 95) 
= 0.30, p = 0.59. In addition, there was no significant interaction between time and treatment 
assignment, F(2, 190) = 2.73, p = 0.076, no significant interaction between time and response status, 
F(2, 190) = 2.63, p = 0.083, no significant interaction between treatment assignment and response 
status, F(1, 95) = 3.23, p = 0.076, and a significant three-way interaction between time, treatment 
assignment, and response status, F(2, 190) = 5.16, p = 0.009, d = 0.468. See Figure 3. However, 
although PMU severity generally decreased across the course of treatment in those who responded to 
CBIT versus showing no such linear trend in other groups, the reduction in PMU severity in those who 
responded to CBIT was not significantly larger than all other groups. The mean reduction in PUTS 
scores across treatment in persons who responded to CBIT (22.67 to 19.08; Mean difference = 3.58, SD 
= 6.39) was greater than those who did not respond to CBIT (22.69 to 23.17; Mean difference = -.52, SD 
= .80) (p = .015), but it was not greater than persons who received PST and either responded (21.75 to 
22.75; Mean Difference = -1.0, SD = 4.32) (p = .51) or did not respond to treatment (20.52 to 19.40; 
Mean difference = 1.33, SD = 4.20) (p = .42). 
 
Figure 3. Repeated measures ANOVA of premonitory urge (PMU) trends across treatment in the adult 
trial. Note: CBIT = Comprehensive Behavioral Intervention for Tics; PST = psychoeducation and 
supportive psychotherapy; PUTS = Premonitory Urge for Tics Scale. Data points reflect estimated 
marginal means and 95% confidence intervals. 
Results failed to support Hypothesis 3, as reductions in PMU severity did not mediate the relationship 
between treatment and outcome. Although there was a significant direct effect with regard to the 
relationship between treatment assignment and changes in YGTSS scores, F(1, 101) = 15.96, p < 0.001, 
there was no significant indirect effect of PMU severity changes (Effect = -0.03; Lower Level Confidence 
Interval = -0.67, Upper Level Confidence Interval = 0.32). 
In exploring the relationship between reductions in PUTS scores and secondary outcome measures, 
there were no significant correlations between PMU severity reductions and changes in OCD 
symptoms, r(104) = -.12, p = .25, depression, r(102) = -.06, p = .52, or anxiety, r(103) = -.17, p = .09. 
Discussion 
Findings from the current study generally do not support the notion that PMU habituation/reduction in 
urge severity is a mechanism of change in behavior therapy for PTDs. In children, reductions in PMU 
severity across treatment were not significantly related to assignment to behavior therapy or response 
status. Adults who received CBIT and responded to treatment showed a significant linear trend 
consistent with PMU severity reductions, but the magnitude of PMU severity reductions in those who 
responded to CBIT was not significantly greater than in all the other study groups. Moreover, 
reductions in PMU severity did not mediate the relationship between treatment and outcome in either 
children or adults, suggesting that even when PMU severity reduction occurs, this process does not 
drive reductions in tic severity. 
Indeed, even though adults who responded to CBIT showed a trend consistent with declining PMU 
severity as compared to other groups, our findings do not satisfy the necessary criteria to establish that 
PMU reductions are mechanisms of change in adult patients. Mediation in clinical trials is evidenced by 
a main effect of treatment, an interaction between treatment and outcome, as well as a significant 
indirect effect of the proposed mediator on the relationship between treatment and outcome 
(Kraemer et al., 2002). Findings from the adult CBIT trial lacked the main effect of treatment but 
showed an interaction between time, treatment, and outcome. In addition, results showed a main 
effect of time. Due to the fact that adult patients who received either behavior therapy or supportive 
therapy showed PMU reductions and because there was no main effect of treatment, we cannot infer 
that PMU habituation is caused by CBIT specifically. 
Present findings necessitate changes in models on the role of PMU habituation in behavior therapy for 
PTDs. Current models suggest that as tics are suppressed, patients are exposed to the PMU experience, 
which initially builds and then gradually dissipates; as this cycle is repeated, patients come to habituate 
to PMUs. As a product of extensive habituation and reduced PMU severity, patients are thought to feel 
less compelled to tic. Instead, our results contradict this model in several ways. First, it appears that 
PMU severity reductions can occur in persons whose tic severity improves without explicit training in 
tic suppression. Perhaps individuals in the adult clinical trial who received PST benefitted from factors 
such as regression toward the mean or therapeutic common factors, and that as their tic severity 
declined they experienced concurrent reductions in PMU severity. Additionally, it is possible that PMUs 
do indeed habituate during CBIT, but PMU habituation is not a large effect that outpaces and drives tic 
reduction. Results from the adult clinical trial showed that although PMUs did show a declining trend in 
those who responded to CBIT relative to other groups, the size of PMU severity reductions in those 
who responded CBIT was not significantly larger than persons who both did and did not respond to 
PST. This would suggest that if PMU habituation does occur in CBIT, it is not a large change that is 
important for outcomes. 
Although study results provide evidence for some degree of PMU severity reductions in adults who 
responded to behavior therapy, children who underwent treatment did not report significant global 
PMU reductions. This suggests that there may be important age-based differences in how PMUs are 
affected by tic treatment. We mentioned earlier that children are less likely to report PMUs, which 
would suggest that with fewer and less severe PMUs, there may be less room for PMU change across 
treatment. Visual inspection of Figure 2, Figure 3 provide support for this notion, in that baseline PMU 
severity was lower in children (M = 17.35) than in adults (M = 21.53). There is also evidence that the 
psychometric properties of the PUTS are less satisfactory in young children, which is a limitation to the 
current study but could also reflect further evidence of age-based differences in PMUs. Indeed, a 
behavioral model of PMU development provides an expanded explanation of the current findings. 
Central to this model is the idea that PMU-tic associations are not solidified until years after tics 
emerge. For instance, researchers have suggested that PMUs emerge and are maintained by not only 
developmental and neurological factors, but also certain environmental events such as aversive 
consequences that accompany tics (Capriotti et al., 2013, Himle et al., 2006, Himle et al., 2014, Woods 
et al., 2005). The underlying neural and somatic correlates of the urge may be present at tic onset, but 
children may fail to recognize these feelings or experience them as nonaversive. As tics continue to 
occur and increase in severity, they result in aversive consequences (e.g., pain, embarrassment; 
Conelea & Woods, 2008). As a result of these consequences, affected children become more vigilant to 
sensations that precede tics, and as with any stimulus that signals an impending aversive event, the 
urges acquire an aversive valence (Woods et al., 2005). Accordingly, as children age and become more 
attuned to PMUs (possibly around age 10), a conditioned association between PMUs and tics develops 
and strengthens. Adults, who may be more attuned to this functional relationship, may be more likely 
to notice that as their tics extinguish and become less frequent, they feel reduced PMUs. By 
comparison, children who are less attuned to PMUs (i.e., those younger than 10) and have weaker 
PMU-tic conditioned associations would be expected to show a less clear relationship between tic 
reductions and PMU reductions. 
It is also possible that children with PTDs may have difficulty in differentiating between “true PMUs” 
and other aversive internal experiences (e.g., sensory underpinnings of negative affect, non-tic somatic 
symptoms) due to insufficiently developed levels of interoceptive awareness and verbal naming 
repertoires required to (a) reliably discriminate between between tic-relevant somatosensory 
experiences and other affective/somatic events, and (b) reliably report on these differences. Although 
speculative, prior research has found child-reported PUTS scores to correlate with scores on anxiety 
and depression measures (Eddy and Cavanna, 2013, Rozenman et al., 2015, Steinberg et al., 2009, 
Woods et al., 2005), and, in the present study, PMU severity reductions in children were associated 
with improvements in depressive symptoms and anxiety sensitivity. 
Findings from the current study have important implications for future research. To date, few 
alternatives to the habituation model of therapeutic change in behavior therapy for PTD have been 
offered, but there does appear to be a specific mechanism of action within behavior therapy for PTDs 
that explains this treatment’s unique ability to generate tic reductions. Analyses from various clinical 
trials indicate that the efficacy of behavior therapy is not the result of common therapeutic factors. 
Specifically, studies have shown that factors such as tic disclosure (Deckersbach, Rauch, Buhlmann, & 
Wilhelm, 2006) and treatment expectancy (Wilhelm et al., 2003) do not account for outcomes in 
behavior therapy for PTDs. Similarly, increased knowledge and validation gained from psychoeducation 
may produce limited change, but does not appear to account for the majority of clinical change in 
behavior therapy (Piacentini et al., 2010, Wilhelm et al., 2012). Despite the paucity of clinical research 
on identified mechanisms of change in behavior therapy of PTDs, there is a relative wealth of 
neurocognitive research suggesting alternative processes that may be at work during behavior therapy 
for PTD. Consistent with this view, a study of adults receiving CBIT demonstrated a nuanced relation 
between changes in left inferior frontal gyrus functioning (known to subserve top-down motor control) 
and decreases in tic severity across treatment (Deckersbach et al., 2014). This model of increased self-
control could be seen as consistent with research on executive control over tics. Laboratory data 
suggest there is an inverse relation between tic severity and performance on a top-down cognitive-
motor control task (Baym, Corbett, Wright, & Bunge, 2008), and that active tic suppression involves 
heightened activity in areas involved in top-down control (e.g., the left inferior frontal gyrus; Ganos et 
al., 2014). A recent review found evidence suggesting that increased control over motor output, which 
could occur due to repeated tic suppression during development, leads to declining tic severity as 
affected individuals age (Jackson, Draper, Dyke, Pépés, & Jackson, 2015). Further, one recent 
investigation failed to find evidence for habituation across periods of reinforced tic suppression in 
children (Specht et al., 2013), but the researchers later reported that tics were less likely to occur 
following severe PMUs that were experienced during reinforced tic suppression periods than following 
less severe PMUs that were experienced during “free to tic” periods (Specht et al., 2014). This may be 
seen as indicating that top-down inhibition, manipulated by proxy in this study via the used of 
reinforcement for tic suppression, led to decreased tic severity in the presence of urges. There are, 
however, negative findings that contradict the notion that inhibitory control is correlated with 
improved tic suppression, as a recent study found that improvements in tic severity during CBIT were 
not associated with performance on a neuropsychological measure of response inhibition 
(Abramovitch et al., 2017). 
In addition to occasioning new directions for future mechanism-focused research, the current study 
has several immediate implications. These data suggest that, when discussing expectations for therapy, 
clinicians should indicate to patients that although PMUs may become fewer and less intense over 
time, treatment really involves learning helpful new ways to manage existing urges. Expectations 
regarding PMU reduction should be expressed with caution, particularly in child and adolescent cases. 
Additionally, changes in urge severity across sessions should not be considered an index of treatment 
progress. Instead, clinicians might consider the patient’s ability to suppress tics in the presence of 
PMUs. A novel approach to managing tics and PMUs in such a way has been tested using mindfulness-
based stress reduction (MBSR; Reese et al., 2015), which teaches patients to respond differently to 
PMUs by observing and tolerating these experiences without ticcing. In a small-scale uncontrolled trial 
of MBSR in older adolescents and adults, researchers found that the intervention was well-tolerated 
and resulted in significant improvements in tic severity and impairment (Reese et al., 2015). Perhaps 
future research should examine such an alternate model of PMU management in PTDs, focusing less 
on PMU reduction and more on the functional relationship between PMUs and tics within each 
individual. 
It should be noted that a significant limitation of this study is that the PUTS may not be the perfect 
instrument for studying nuanced changes in PMU severity over time. Although results of this study 
support the notion that the PUTS can detect changes in PMUs over time, it could be argued that 
research on PMU habituation may benefit from assessment on a finer temporal scale (e.g., every 15s), 
as has been done in laboratory-based tic suppression studies (Capriotti et al., 2014, Capriotti et al., 
2014, Himle et al., 2007, Specht et al., 2013). Moreover, different tics are associated with different 
PMUs, and CBIT is meant to target only bothersome tics and ignore benign tics (e.g., McGuire et al., 
2015). This means that certain PMUs may be affected by CBIT while others remain unchanged, which 
could limit reductions in the overall PUTS score despite patients feeling that their most bothersome 
PMUs have reduced significantly. An ideal way in which to maximize the validity of PMU assessment 
during treatment would be to gather a continuous measure of urge severity from those urges that are 
tied to targeted tics, measure several different urges simultaneously, and summarize overall PMU 
severity. Examination of PUTS item content also reveals that the measure could be characterized as 
more an inventory of different types of urge experiences, rather than a multidimensional assessment 
of urge frequency, intensity, and resistance to change. Future studies on therapeutic processes in 
behavior therapy for PTDs may benefit from using assessment measures designed to measure such 
important constructs, such as the Individualized Premonitory Urge for Tics Scale, which measures 
PMUs severity on a tic-by-tic basis (McGuire et al., 2016). 
Conclusion 
Research on behavior therapy for PTDs is burgeoning, and increasing efforts are being made to 
understand the processes through which these treatments work. At odds with the dominant 
habituation model, this study found that although adults who respond to CBIT show PMU severity 
reductions, children who receive CBIT do not show PMU severity reductions, and PMU severity 
reductions do not mediate change. These results suggest that more attention be devoted to processes 
of change in behavior therapy for PTDs, with specific consideration of alternative models of change. 
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